Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.12 – $1.43
99% from low
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $18.5K | $71.7K | $366.3K | $391.4K | $123.6K | $113.5K | $0 | $0 |
| Gross profit | −$18.5K | −$71.7K | −$366.3K | −$391.4K | −$123.6K | −$113.5K | −$121.9K | $0 |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $617.0K | $2.5M | $4.7M | $15.7M | $8.4M | $4.2M | $2.7M | $537.4K |
| Operating income | −$3.2M | −$11.0M | −$11.9M | −$23.4M | −$116.1M | −$38.6M | −$81.6M | −$189.0M |
| EBITDA | −$5.3M | −$17.9M | −$11.5M | −$23.3M | −$112.9M | −$39.0M | −$79.5M | −$188.8M |
| Net income | −$6.3M | −$18.0M | −$11.4M | −$26.7M | −$113.4M | −$39.7M | −$80.7M | −$178.0M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -2.90 | -4.80 | -2.50 | -5.70 | -21.60 | -7.10 | -8.40 | -1.08 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds RENB.
No tracked institution reports a position in RENB as of their last filing.
No one on the platform has traded RENB yet.
| $37M |
| — |
| IRDOpus Genetics, Inc. | $4.06 | +1.50% | $335M | — |
| LIANYLianBio | $0.12 | -28.13% | $13M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.